ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Discovery of sultam-containing small-molecule disruptors of the huntingtin–calmodulin protein–protein interaction
dc.contributor.author | Klus, Nicholas J. | |
dc.contributor.author | Kapadia, Khushboo | |
dc.contributor.author | McDonald, Peter | |
dc.contributor.author | Roy, Anuradha | |
dc.contributor.author | Frankowski, Kevin J. | |
dc.contributor.author | Muma, Nancy A. | |
dc.contributor.author | Aubé, Jeffrey | |
dc.date.accessioned | 2022-02-01T16:21:24Z | |
dc.date.available | 2022-02-01T16:21:24Z | |
dc.date.issued | 2020-06-12 | |
dc.identifier.citation | Klus, N.J., Kapadia, K., McDonald, P. et al. Discovery of sultam-containing small-molecule disruptors of the huntingtin–calmodulin protein–protein interaction. Med Chem Res 29, 1187–1198 (2020). https://doi.org/10.1007/s00044-020-02583-8 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/32487 | |
dc.description.abstract | The aberrant protein–protein interaction between calmodulin and mutant huntingtin protein in Huntington’s disease patients has been found to contribute to Huntington’s disease progression. A high-throughput screen for small molecules capable of disrupting this interaction revealed a sultam series as potent small-molecule disruptors. Diversification of the sultam scaffold afforded a set of 24 analogs or further evaluation. Several structure–activity trends within the analog set were found, most notably a negligible effect of absolute stereochemistry and a strong beneficial correlation with electron-withdrawing aromatic substituents. The most promising analogs were profiled for off-target effects at relevant kinases and, ultimately, one candidate molecule was evaluated for neuroprotection in a neuronal cell model of Huntington’s disease. | en_US |
dc.publisher | Springer | en_US |
dc.rights | Copyright © 2020, Springer Science Business Media, LLC, part of Springer Nature. | en_US |
dc.subject | Huntington’s disease | en_US |
dc.subject | High-throughput screening | en_US |
dc.subject | Neurodegeneration | en_US |
dc.subject | Structure–activity relationship studies | en_US |
dc.title | Discovery of sultam-containing small-molecule disruptors of the huntingtin–calmodulin protein–protein interaction | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Kapadia, Khushboo | |
kusw.kuauthor | McDonald, Peter | |
kusw.kuauthor | Roy, Anuradha | |
kusw.kuauthor | Muma, Nancy A. | |
kusw.kudepartment | Pharmacology and Toxicology | en_US |
kusw.kudepartment | High-Throughput Screening Laboratory | en_US |
dc.identifier.doi | 10.1007/s00044-020-02583-8 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC7906539 | en_US |
dc.rights.accessrights | openAccess | en_US |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [299]